Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:III-20-III-26
doi: 10.1161/01.CIR.0000131514.71167.2e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paoletti, R.
Right arrow Articles by Hajjar, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paoletti, R.
Right arrow Articles by Hajjar, D. P.

(Circulation. 2004;109:III-20 – III-26.)
© 2004 American Heart Association, Inc.


Atherosclerosis: Evolving Vascular Biology and Clinical Implications

Inflammation in Atherosclerosis and Implications for Therapy

Rodolfo Paoletti, MD, PhD; Antonio M. Gotto, Jr, MD, DPhil; David P. Hajjar, PhD

From the Department of Pharmacological Sciences (R.P.), University of Milan, Milan, Italy; and Weill Medical College of Cornell University (A.M.G., D.P.H.), New York, NY.

Correspondence to Rodolfo Paoletti, MD, Department of Pharmacological Sciences, University of Milan, via Balzaretti 9, 20133, Milan, Italy. E-mail rodolfo.paoletti{at}unimi.it

Atherosclerosis is now understood to be a disease characterized by inflammation that results in a host of complications, including ischemia, acute coronary syndromes (unstable angina pectoris and myocardial infarction), and stroke. Inflammation may be caused by a response to oxidized low-density lipoproteins, chronic infection, or other factors; and markers of this process, such as C-reactive protein, may be useful to predict an increased risk of coronary heart disease. Thus, we believe that inflammatory processes may be potential targets of therapy in preventing or treating atherosclerosis and its complications.


Key Words: atherosclerosis • coronary heart disease • C-reactive protein • inflammation • risk factors




This article has been cited by other articles:


Home page
Diabetes and Vascular Disease ResearchHome page
B. A Brooks, S. V McLennan, S. M Twigg, and D. K Yue
Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications
Diabetes and Vascular Disease Research, March 1, 2008; 5(1): 30 - 35.
[Abstract] [PDF]